Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:53 AM
Ignite Modification Date:
2025-12-25 @ 3:53 AM
NCT ID:
NCT04693702
Eligibility Criteria:
Inclusion Criteria:
1. \- Female or male
2. \- Any race
3. \- Patient is at least 50 years old
4. \- Patient has diagnosed retinal disorder that causes central vision loss in one or both eyes
5. \- Treated eyes, at time of treatment, were pseudophakic or phakic with no significant vision loss due to cataract
6. \- Patient had moderate to severe baseline vision impairment with CDVA of 20/63 or worse (decimal = 0.317 or less; logMAR greater than or equal to 0.50) in the treated eye(s)
7. \- Patient CDVA records are available at baseline and at 1m or longer post-Tx times
Exclusion Criteria:
1 - Corneal disease or disorder in either eye 2 - Increased intraocular pressure (above 20mm Hg), glaucoma or history of glaucoma 3 - Presence or history of any other condition or finding that, in the opinion of the investigator, makes the patient unsuitable for retrospective observational study
\-
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
100 Years
Study:
NCT04693702
Study Brief:
Protocol Section:
NCT04693702